0001127602-22-002068.txt : 20220125
0001127602-22-002068.hdr.sgml : 20220125
20220125165738
ACCESSION NUMBER: 0001127602-22-002068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220121
FILED AS OF DATE: 20220125
DATE AS OF CHANGE: 20220125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Timothy Eugene
CENTRAL INDEX KEY: 0001707000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 22554616
MAIL ADDRESS:
STREET 1: 800 BOYLSTON ST., SUITE 3310
STREET 2: PRUDENTIAL TOWER C/O AJU IB INVESTMENT
CITY: BOSTON
STATE: MA
ZIP: 02199
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-01-21
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001707000
Sullivan Timothy Eugene
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Chief Financial Officer
Common Stock
2022-01-21
4
A
0
30787
0
A
104928
D
Stock Option (Right to Buy)
35.46
2022-01-21
4
A
0
43670
0
A
2032-01-20
Common Stock
43670
43670
D
This represents a restricted stock unit grant made on January 21, 2022 that vests 25% annually in equal installments over four years from the date of grant, subject to continued service.
This represents a non-qualified stock option grant made on January 21, 2022 that vests over a four year period with 25% vesting one year from grant date and the remaining 75% vesting in equal monthly installments thereafter through the fourth anniversary of the grant date, subject to continued service.
/s/ David Watson as attorney-in-fact for Timothy Sullivan
2022-01-25